Belgium Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Published by: Global Markets Direct

Published: Sep. 28, 2009 - 68 Pages

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

3 Definitions of the Markets Covered in the Report

3.1 Drug Delivery Devices

3.2 Inhalation Systems

3.2.1 Metered Dose Inhaler

3.2.2 Dry Powder Inhaler

3.3 Infusion Systems

3.3.1 Infusion Pumps

3.3.2 Syringe Pumps

3.3.3 Disposable Infusion Sets

4 Healthcare Sector Review

4.1 Healthcare Expenditure

4.2 Healthcare Infrastructure

4.2.1 Healthcare Personnel Data

4.2.2 Healthcare Facilities Data

4.3 Healthcare Policy

5 Regulation System

5.1 Medical Equipment Approval Process

5.1.1 Classification

5.1.2 Conformity Assessment Process

5.1.2.1 Class I devices

5.1.2.2 Class IIa devices

5.1.2.3 Class IIb devices

5.1.2.4 Class III devices

5.2 Notification Fee

6 Pricing and Reimbursement

6.1 Reimbursement Policies

7 Distribution Structure

8 Drug Delivery Devices In Belgium

8.1 Drug Delivery Devices, Belgium, Overall Revenue ($ mn), 2000-2015

8.2 Drug Delivery Devices, Belgium, Category Volume (Units), 2000-2015

8.3 Drug Delivery Devices, Belgium, Company Share (2007-2008)

9 Infusion Systems In Belgium

9.1 Infusion Systems Overall Revenue (2000-2015)

9.2 Infusion Systems Overall Volume (2000-2015)

9.3 Infusion Systems Average Price (2000-2015)

9.4 Infusion Systems Distribution Share (2007-2008)

9.5 Infusion Systems, Belgium, Company Share (2007-2008)

10 Inhalation Systems In Belgium

10.1 Inhalation Systems Overall Revenue (2000-2015)

10.2 Inhalation Systems Overall Volume (2000-2015)

10.3 Inhalation Systems Average Price (2000-2015)

10.4 Inhalation Systems Distribution Share (2007-2008)

10.5 Inhalation Systems, Belgium, Company Share (2007-2008)

11 Overview of Key Companies in Belgium Drug Delivery Devices Market

11.1 Terumo Corporation

11.1.1 Company Overview

11.2 Smiths Medical

11.2.1 Company Overview

11.3 Novartis AG

11.3.1 Company Overview

11.4 Hospira, Inc.

11.4.1 Company Overview

11.5 GlaxoSmithKline plc

11.5.1 Company Overview

11.6 Fresenius Kabi AG

11.6.1 Company Overview

11.7 Cardinal Health, Inc.

11.7.1 Company Overview

11.8 Boehringer Ingelheim GmbH

11.8.1 Company Overview

11.9 Consort Medical plc

11.9.1 Company Overview

11.9.2 Bespak plc Pipeline Products

11.9.2.1 Bespak plc Pipeline Products By Equipment Type

11.9.2.2 Bespak plc Pipeline Products By Development Stage

11.9.2.3 Bespak plc Pipeline Products By Therapy Area

11.10 Baxter International Inc.

11.10.1 Company Overview

11.11 B. Braun Melsungen AG

11.11.1 Company Overview

11.12 AstraZeneca PLC

11.12.1 Company Overview

11.13 H&O Equipments nv

11.13.1 Company Overview

12 Appendix

12.1 Global Markets Direct Research Methodology

12.2 Secondary Research

12.3 Primary Research

12.4 Models

12.5 Forecasts

12.6 Expert Panel Validation

12.7 Currency Conversion

12.8 Contact Us

12.9 Disclaimer

1.1 List of Tables

Table 1: Healthcare Expenditure in Belgium, 2000 - 2007

Table 2: Hospitals and Hospital Beds in Belgium, 2005

Table 3: Number of Doctors by Specialty in Belgium, 2003-2007

Table 4: Number of Hospital Wards by Specialty in Belgium, 2003-2007

Table 5: Medical Equipment Notification Fee in Belgium, 2007

Table 6: Drug Delivery Devices, Belgium, Overall Revenue ($ mn), 2000-2015

Table 7: Drug Delivery Devices, Belgium, Cross-Category Analysis, 2000-2015

Table 8: Drug Delivery Devices, Belgium, Overall Revenue ($ mn), Historic, 2000-2008

Table 9: Drug Delivery Devices, Belgium, Overall Revenue ($ mn), Forecast, 2008-2015

Table 10: Drug Delivery Devices, Belgium, Category Volume (Units), 2000-2015

Table 11: Drug Delivery Devices, Belgium, Category Volume (Units), Historic, 2000-2008

Table 12: Drug Delivery Devices, Belgium, Category Volume (Units), Forecast, 2008-2015

Table 13: Drug Delivery Devices, Belgium, Company Share by Revenue ($ mn), 2007-2008

Table 14: Infusion Systems, Belgium, Revenue ($ mn) by Segment, Historic, 2000-2008

Table 15: Infusion Systems, Belgium, Revenue ($ mn) by Segment, Forecast, 2008-2015

Table 16: Infusion Systems, Belgium, Volume (Units) by Segment, Historic, 2000-2008

Table 17: Infusion Systems, Belgium, Volume (Units) by Segment, Forecast, 2008-2015

Table 18: Infusion Systems, Belgium, Average Price ($), Historic, 2000-2008

Table 19: Infusion Systems, Belgium, Average Price ($), Forecast, 2008-2015

Table 20: Infusion Systems, Belgium, Distribution Share by Revenue ($mn), 2007-2008

Table 21: Infusion Systems, Belgium, Company Share by Revenue ($ mn), 2007-2008

Table 22: Inhalation Systems, Belgium, Revenue ($ mn) by Segment, Historic, 2000-2008

Table 23: Inhalation Systems, Belgium, Revenue ($ mn) by Segment, Forecast, 2008-2015

Table 24: Inhalation Systems, Belgium, Volume (Units) by Segment, Historic, 2000-2008

Table 25: Inhalation Systems, Belgium, Volume (Units) by Segment, Forecast, 2008-2015

Table 26: Inhalation Systems, Belgium, Average Price ($), Historic, 2000-2008

Table 27: Inhalation Systems, Belgium, Average Price ($), Forecast, 2008-2015

Table 28: Inhalation Systems, Belgium, Distribution Share by Revenue ($mn), 2007-2008

Table 29: Inhalation Systems, Belgium, Company Share by Revenue ($ mn), 2007-2008

Table 30: Bespak plc Pipeline Products by Equipment Type

Table 31: Bespak plc Pipeline Products By Development Stage

Table 32: Bespak plc Pipeline Products By Therapy Area

Table 33: USD to Local Currency, Average Exchange Rate 2008

1.2 List of Figures

Figure 1: Total Healthcare Expenditure in Belgium, 2000 - 2007

Figure 2: Government and Private Healthcare Expenditure in Belgium, 2007

Figure 3: Structure of Healthcare System in Belgium, 2007

Figure 4: Flowchart for Classification of Non-invasive Devices in Belgium, 2007

Figure 5: Flowchart for Classification of Invasive Devices in Belgium, 2007

Figure 6: Flowchart for Classification of Invasive Devices in Belgium, 2007

Figure 7: Flowchart for Classification of Invasive Devices in Belgium, 2007

Figure 8: Flowchart for Classification of Invasive Devices in Belgium, 2007

Figure 9: Flowchart for Classification of Active Devices in Belgium, 2007

Figure 10: Flowchart for Classification of Active Devices in Belgium, 2007

Figure 11: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Belgium, 2007

Figure 12: Conformity Assessment of Class-I Medical Devices in Belgium, 2007

Figure 13: Conformity Assessment of Class-IIa Medical Devices in Belgium, 2007

Figure 14: Conformity Assessment of Class-IIb Medical Devices in Belgium, 2007

Figure 15: Conformity Assessment of Class-III Medical Devices in Belgium, 2007

Figure 16 Drug Delivery Devices, Belgium, Overall Revenue ($ mn), 2000-2015

Figure 17: Drug Delivery Devices, Belgium, Cross-Category Analysis, 2000-2015

Figure 18 Drug Delivery Devices, Belgium, Overall Revenue ($ mn), Historic, 2000-2008

Figure 19 Drug Delivery Devices, Belgium, Overall Revenue ($ mn), Forecast, 2008-2015

Figure 20 Drug Delivery Devices, Belgium, Category Volume (Units), 2000-2015

Figure 21 Drug Delivery Devices, Belgium, Category Volume (Units), Historic, 2000-2008

Figure 22 Drug Delivery Devices, Belgium, Category Volume (Units), Forecast, 2008-2015

Figure 23 Drug Delivery Devices, Belgium, Company Share (%), 2008

Figure 24 Infusion Systems, Belgium, Revenue ($ mn) by Segment, Historic, 2000-2008

Figure 25 Infusion Systems, Belgium, Revenue ($ mn) by Segment, Forecast, 2008-2015

Figure 26 Infusion Systems, Belgium, Company Share (%), 2008

Figure 27 Inhalation Systems, Belgium, Revenue ($ mn) by Segment, Historic, 2000-2008

Figure 28 Inhalation Systems, Belgium, Revenue ($ mn) by Segment, Forecast, 2008-2015

Figure 29 Inhalation Systems, Belgium, Volume (Units) by Segment, Historic, 2000-2008

Figure 30 Inhalation Systems, Belgium, Volume (Units) by Segment, Forecast, 2008-2015

Figure 31 Inhalation Systems, Belgium, Company Share (%), 2008

Figure 32 Global Markets Direct Methodology

Abstract

• The report provides information on the drug delivery devices market in Belgium.
• Details on the key segments and categories such as Inhalation Systems, Needle Free Injections, and Infusion Systems.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors such as AstraZeneca International plc, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Baxter International Inc., and Hospira, Inc.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

• Gain a strong understanding of the drug delivery devices market in Belgium.
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Plan deal strategies with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.